Genomax Technologies is a Singapore-based company, established in 2003, with regional offices in Singapore, Malaysia, and Thailand. The company specializes in biotechnology and pharmaceutical industries, offering positioning solutions in bioinformatics, clinical, genomics, molecular cell biology, and proteomics. As a trusted distributor of scientific products and services, Genomax Technologies caters to a wide array of clients including life science research communities, biotechnology and pharmaceutical companies, clinical research organizations, and hospitals. The company prides itself on its commitment to offering high-quality products and services in compliance with ISO 9001:2015 and SS 620:2016 Good Distribution Practice for Medical Devices (GDPMDS). Additionally, they ensure excellent technical support, friendly customer service, and fast delivery, with a pledge to continually improve the effectiveness of their business management system and enhance the customer's total experience. Genomax Technologies emphasizes conducting its business in strict compliance with the law and adheres to the highest principles of business ethics. Currently, there is no public information available regarding the company's last investment or its investors. Overall, with its comprehensive range of offerings and commitment to quality and ethical practices, Genomax Technologies presents an intriguing opportunity in the biotechnology and pharmaceutical sectors for potential investors.
There is no investment information
No recent news or press coverage available for Genomax Technologies.